.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ETMM back up to .015...
GLTA!
If we really get a PR w/ the website launch... KABOOM!!
JMO.
GLTA!
I leave for an hour and come back to this! Awesome!
GO IDGI!!!
GLTA!
Nice find!
Moody's downgrades Liz Claiborne's rating to 'B3'
http://www.marketwatch.com/story/moodys-downgrades-liz-claibornes-rating-to-b3-2009-11-19?siteid=yhoof2
.004x.0041
GLTA!
iBOX Updated!
Lyric Culture is in Bloomingdale's?
Short Interest (according to ShortSqueeze.com):
Macys Inc.
Short Interest (Shares Short)
36,033,100
Days To Cover (Short Interest Ratio)
3.2
Short Percent of Float
8.58 %
Short Interest - Prior
35,967,400
Short % Increase / Decrease
0.18 %
Short Squeeze Ranking™
52
% From 52-Wk High ($ 20.84 )
-20.62 %
% From 52-Wk Low ($ 5.07 )
70.66 %
% From 200-Day MA ($ 14.96 )
13.42 %
% From 50-Day MA ($ 18.63 )
-7.82 %
Price % Change (52-Week)
190.10 %
Shares Float
419,890,000
Total Shares Outstanding
420,523,244
% Owned by Insiders
8.95 %
% Owned by Institutions
82.40 %
Market Cap.
$ 7,265,842,662
Trading Volume - Today
1,428,525
Trading Volume - Average
11,108,500
Trading Volume - Today vs. Average
12.86 %
Earnings Per Share
-11.60
PE Ratio
Record Date
2009-NovA
The company currently expects same-store sales to be down 1 percent to 2 percent in the fourth quarter of 2009, which calculates to down 2.1 percent to 2.6 percent in the second half of 2009. This is better than previous guidance for second half same-store sales to be down 5 percent to 6 percent. At the level of current guidance for the fourth quarter, full-year 2009 same-store sales are expected to be down between 5.4 percent and 5.7 percent – better than the company’s original guidance, provided at the beginning of the year, for fiscal 2009 same-store sales to be down between 6 percent and 8 percent.
Macy’s, Inc. is assuming fourth quarter earnings per share on a diluted basis will be $1.00 to $1.05 per share, excluding restructuring-related costs. At the level of current guidance for the fourth quarter, full-year 2009 diluted earnings per share will be $1.01 to $1.06, excluding restructuring-related costs. This is an increase from previous guidance (provided in August 2009) for 70 cents to 80 cents per share on the same basis. (Original guidance for fiscal 2009 earnings per share, provided at the beginning of the year, was 40 cents to 55 cents per diluted share, excluding restructuring-related costs.) The company continues to expect to book a total of approximately $400 million in pre-tax restructuring-related costs.
Macy's, Inc., with corporate offices in Cincinnati and New York, is one of the nation's premier retailers, with fiscal 2008 sales of $24.9 billion. The company operates more than 850 department stores in 45 states, the District of Columbia, Guam and Puerto Rico under the names of Macy's and Bloomingdale's. The company also operates macys.com and bloomingdales.com. Prior to June 1, 2007, Macy's, Inc. was known as Federated Department Stores, Inc.
All statements in this press release that are not statements of historical fact are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are based upon the current beliefs and expectations of Macy’s management and are subject to significant risks and uncertainties. Actual results could differ materially from those expressed in or implied by the forward-looking statements contained in this release because of a variety of factors, including conditions to, or changes in the timing of, proposed transactions, prevailing interest rates, changes in expected synergies, cost savings and non-recurring charges, competitive pressures from specialty stores, general merchandise stores, manufacturers' outlets, off-price and discount stores, new and established forms of home shopping (including the Internet, mail-order catalogs and television) and general consumer spending levels, including the impact of the availability and level of consumer debt, the effect of weather and other factors identified in documents filed by the company with the Securities and Exchange Commission.
11/11/2009 -- Macy's, Inc. Reports Stronger-Than-Expected Third Quarter Results -- http://finance.yahoo.com/news/Macys-Inc-Reports-bw-2513859915.html?x=0&.v=1
I have the same problem. Owned CVM @ .58 sold @ .56. :(
I'll take a look @ CRBC.
GLTA!
Sure hope so (I got in ~2.5x)... Can't believe that it went this low...
GLTA!
Yeah. IVOB has GREAT potential, in my opinion!
And IF they get FDA approval in the next 1-2 years.... Wow....
JMO.
GLTA!
37-38 now...
GLTA!
Come on IDGI, let's close at the HOD!
GO IDGI!
GLTA!
Yeah, especially not on a bulletin board stock!
GLTA!
Awesome! That explains the nice PPS increase today...
GLTA!
I snatched up some more at .0036...
GLTA!
If IDGI gets a licensing deal w/ Macy's or JCPenney, $1 might not seem so outrageous after all, IMO.
JMO.
GLTA!
$12 would be very nice...
GLTA!
I agree. My favorite apparel/retail stock is LIZ. They've gotten pretty beat up by the market crash, and in Fall 2010 JCPenney will start to sell their products. Could make a great recovery story, in my opinion.
JMO.
GLTA!
Possibly, but IMO unless you're investing with a 1-2 year perspective, DSCO is not that great of a buy right now.
JMO.
GLTA!
11/4/2009 -- Liz Claiborne Inc. Reports 3rd Quarter and First Nine Months Results -- http://finance.yahoo.com/news/Liz-Claiborne-Inc-Reports-3rd-prnews-289920458.html?x=0&.v=1
GLTA!
IMO the JCPenney deal is pretty significant..
JMO.
GLTA!
US FDA approves NeurogesX Qutenza pain patch -- http://www.reuters.com/article/marketsNews/idCNN1652335920091116?rpc=44
GLTA LONGS!
Woohoo! According to Scottrade (haven't checked E*TRADE yet), the closing price was $1!
GLTA!
Yeah, that's what I meant. He really believes in the science, as do I, and you (and many others). It's great news for the AML AND Ovarian cancer patients, and I hope ENMD-2076 continues to show promising results for all other types of cancer as well.
ENMD has lots of potential, in my opinion. And I'm not selling any of my shares anywhere below $5+.
Also, we actually made money in the 3Q, for the first time in the company's history, I believe! :)
I don't know George, but I believe that he's a great guy, and people who are blaming him for their loss shouldn't have bought ENMD in the first place, and were just looking to make a quick buck. ENMD is a longer term stock, not for flippers, in my opinion.
GLTA!
Yeah... You are correct.
Hopefully ENMD won't go down further.
GLTA!
Yeah. But it's not his fault, he just really believes in the science behind ENMD-2076.
Hopefully we can close at or over $1.
GLTA.
And here come the pennies...
Got your PM, can't reply cuz I don't have a premium subscription (I'm too cheap, lol). If you want, send me an email (it's my iHub username @gmail.com
GLTA!
Don't like today's action... Hopefully we'll turn around by EOD.
GLTA!
Looks like it may take another leg up later today, imo.
JMO.
GLTA!
Looking pretty good today, imo. Let's see how the advisory committee meeting goes this afternoon.
Anyone going to be watching the meeting?
GLTA!
1.45 (Bid) x 1.54 (Ask)
GLTA!
We were green, then all of a sudden turned red... Grrr...
GLTA!
Promising interim results, imo. Only question is why isn't this going up more?? lol.
GLTA!